Nicholas Investment Partners’s Medicines Co MDCO Stock Holding History

Nicholas Investment Partners’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-48,252	Closed	-$4.1M	–	216
2019 Q4	$4.1M	Sell	48,252 -109,220	-69%	-$7.28M	0.42%	80
2019 Q3	$7.87M	Buy	157,472 +141,515	+887%	+$5.65M	0.66%	41
2019 Q2	$582K	Buy	+15,957	New	+$521K	0.05%	202
2016 Q4	–	Sell	-121,678	Closed	-$4.59M	–	357
2016 Q3	$4.59M	Hold	121,678	–	–	0.31%	113
2016 Q2	$4.09M	Buy	121,678 +67,195	+123%	+$2.37M	0.28%	133
2016 Q1	$1.73M	Sell	54,483 -27,937	-34%	-$912K	0.13%	256
2015 Q4	$3.08M	Buy	+82,420	New	+$3.11M	0.21%	202
2013 Q3	–	Sell	-51,210	Closed	-$1.57M	–	338
2013 Q2	$1.57M	Buy	+51,210	New	+$1.71M	0.15%	232

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Nicholas Investment Partners's MDCO Position: Q1 2020 in Review

Nicholas Investment Partners sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 48,252 shares — an estimated $4.1M sold.

Nicholas Investment Partners first reported a position in MDCO in Q2 2013 and held it in 8 quarters. The position peaked at $7.87M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Nicholas Investment Partners reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Nicholas Investment Partners sold 48,252 Medicines Co shares in Q1 2020, an estimated $4.1M.
Nicholas Investment Partners first reported a position in Medicines Co in Q2 2013 and held it in 8 quarters.
Nicholas Investment Partners's Medicines Co position peaked at $7.87M in Q3 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Nicholas Investment Partners's 13F filing for Q1 2020, filed 13 May 2020.